Royal Bank of Canada (RY)
Toronto Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 282.78 |
|---|---|
| 52-week range | 201.76 – 306.38 |
| Return, 1 month / 3 months | −1.5% / −4.5% |
| Return, 1 year / 3 years | +41.6% / +182.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 53 |
| Volatility (1 year) | 15.3% |
| Worst drawdown (1 year) | -10.9% |
| Average daily value traded | 898.30M CAD |
| Dividend yield | 2.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Royal Bank of Canada is a diversified financial services company based in Toronto. It provides personal and commercial banking, wealth management and insurance services to individuals and businesses, mainly in Canada, and also serves clients in the United States and other markets. Its capital markets arm offers advisory, underwriting and trading services to corporate and institutional clients, while its investor and treasury services unit handles custody and fund services.
Royal Bank of Canada trades under the code RY on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Royal Bank of Canada (RY) trades on the Toronto Exchange in Canada. It last closed at CAD 282.78 on 22 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 21 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 41.6% and over the last three months it fell 4.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.9% | ||
| From 52-week high | -7.5% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.5% | ||
| 6-month return | 18.7% | ||
| 12-month return, skipping the last month | 43.8% | ||
| Stability (higher is calmer) | 94 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 15.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.9% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 898.30M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | −1.5% |
| 3 months | −4.5% |
| 6 months | +18.7% |
| 1 year | +41.6% |
| 3 years | +182.6% |
| 5 years | +154.0% |
Signals
| 50-day / 200-day average | 284.35 / 259.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Oct 2026 | CAD 1.7600 |
| 27 Jul 2026 | CAD 1.7600 |
| 23 Apr 2026 | CAD 1.6400 |
| 26 Jan 2026 | CAD 1.6400 |
| 27 Oct 2025 | CAD 1.5400 |
| 24 Jul 2025 | CAD 1.5400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.